Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today

Pfizer bows, but is not entirely out of the GLP-1 race.Bad news for Pfizer (PFE 1.19%) turned into good news for Eli Lilly (LLY 2.50%), Novo Nordisk (NVO 2.21%), and Viking Therapeutics (VKTX 8.78%) Monday morning, each of which is rising on Pfizer's latest product announcement.Early this morning, Pfizer announced it will discontinue development of its danuglipron (PF-06882961) once-a-day oral GLP-1 weight loss pill. Shares of companies will injectable GLP-1 drugs already on the market -- Eli Lilly and Novo ...